Company Deploy Safety and Environmental Protection Work in 2019
Release time:
2020-07-22
Company Deploys 2019 Safety and Environmental Protection Work
News 1# September 31 On the afternoon of September , the Group Company held an annual safety and environmental protection work conference attended by members of the safety committee, heads of safety and environmental protection of various enterprises and heads of functional departments and offices of the headquarters to summarize and review the safety and environmental protection work in 2018 , the new year related work requirements. In
2018 , the company further strengthened daily supervision and implemented the main responsibility of safety production by focusing on the safety education year, the establishment of safety and environmental protection accident-free factories and the anti-"habitual violation" activities. Compile the "Safety Education Reader", organize various forms of training, drills and exchanges, and popularize safety and environmental protection knowledge; Vigorously carry out relevant technological transformation and innovation, improve and upgrade safety and environmental protection facilities, and improve the level of daily safety and environmental protection work. The safety production and construction of engineering projects within the group are generally safe and stable throughout the year. There are no major personal injuries and property losses. There are no fire, explosion and poisoning accidents with a direct economy of more than 190000 yuan. There are no major equipment liability accidents. Environmental protection, fire protection and occupational health operations are generally good. The accident rate for the whole year was 0.265% , successfully fulfilling the requirements of the safety production target responsibility system and the group company's safety internal control index 0.5% issued by the municipal economic and information Committee. The
2019 safety and environmental protection work: continue to carry out the activities of creating safety and environmental protection "accident-free factories" and implement the safety and environmental protection responsibility system; Continue to strengthen safety education, organize safety training twice, try out the high-speed rail safety education mode, and carry out targeted safety education; Strengthen the assessment of illegal behaviors, linking the assessment of illegal behaviors with salary increase and evaluation, and giving full play to the role of enterprise safety award; Formulate and try out a regular safety management evaluation system, and regularly conduct a comprehensive evaluation of relevant enterprise systems, procedures, on-site facilities, instructions, environment, etc.; Try out clean and civilized production management standards in cement enterprises; organize a safety speech contest to promote the construction of the company's safety culture.
2018 safety production responsibility system with various professional companies and directly affiliated enterprises on behalf of the group company.
2018 , the safety and environmental protection responsibility system and the personal safety risk fund assessment were also reported, and the peak pharmaceutical qiubin pharmaceutical factory, international trading company, pharmaceutical company (headquarters and commerce) and cable company that obtained the safety and environmental protection accident-free factory were rewarded. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31